HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)

Market Cap	6.05B +20.9%
Revenue (ttm)	10.22B -0.3%
Net Income	119.14M -53.8%
EPS	0.21 -53.7%
Shares Out	579.89M
PE Ratio	50.76
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	29,220,590
Average Volume	15,509,255
Open	10.71
Previous Close	10.99
Day's Range	10.40 - 11.18
52-Week Range	6.40 - 18.13
Beta	0.29
RSI	48.66
Earnings Date	Apr 11, 2026

About SHA:600829

HPGC Renmintongtai Pharmaceutical Corporation engages in the wholesale and retail of pharmaceutical products in China and internationally. The company offers Chinese and Western patent medicines, Chinese herbal medicines and slices, chemical preparations, antibiotics, biological products, biochemical drugs, medical devices, and health products, as well as tonic health, daily necessities, and cosmetics products. It also provides logistics services, including warehousing and distribution services; and hospital services comprising medical treatmen...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1950
• Employees: 2,870
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600829

Financial Performance

In 2024, SHA:600829's revenue was 10.05 billion, a decrease of -3.29% compared to the previous year's 10.39 billion. Earnings were 213.27 million, a decrease of -27.00%.